# Terazosin

NDC: 70518-4545
Generic name: Terazosin
Labeler / Manufacturer: REMEDYREPACK INC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20260113

FDA application: ANDA075667

## Active ingredients

- TERAZOSIN HYDROCHLORIDE: 2 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70518-4545"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70518-4545
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a16abe41-98e7-4e60-8c1b-911c6a29f0a2